[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2020 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Mar-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- -18.72%
YoY- 118.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 4,103,297 1,970,622 793,499 2,725,071 2,090,488 1,465,684 819,921 192.29%
PBT 151,987 53,768 31,524 35,793 49,299 45,206 30,880 189.06%
Tax -64,947 -17,052 -8,696 -9,524 -15,983 -13,184 -8,465 288.52%
NP 87,040 36,716 22,828 26,269 33,316 32,022 22,415 146.84%
-
NP to SH 86,675 36,840 23,136 27,489 33,820 32,378 22,399 146.27%
-
Tax Rate 42.73% 31.71% 27.59% 26.61% 32.42% 29.16% 27.41% -
Total Cost 4,016,257 1,933,906 770,671 2,698,802 2,057,172 1,433,662 797,506 193.51%
-
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 56,292 30,100 10,468 28,761 26,139 22,204 15,673 134.34%
Div Payout % 64.95% 81.71% 45.25% 104.63% 77.29% 68.58% 69.98% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
NOSH 1,309,126 261,991 261,705 261,705 261,705 261,705 261,229 192.55%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 2.12% 1.86% 2.88% 0.96% 1.59% 2.18% 2.73% -
ROE 22.14% 10.31% 6.50% 8.15% 9.80% 9.05% 6.40% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 313.44 150.58 303.20 1,042.20 799.75 561.06 313.87 -0.09%
EPS 6.62 2.82 8.84 10.51 12.94 12.39 8.57 -15.79%
DPS 4.30 2.30 4.00 11.00 10.00 8.50 6.00 -19.89%
NAPS 0.299 0.273 1.36 1.29 1.32 1.37 1.34 -63.17%
Adjusted Per Share Value based on latest NOSH - 261,705
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 284.71 136.73 55.06 189.08 145.05 101.70 56.89 192.29%
EPS 6.01 2.56 1.61 1.91 2.35 2.25 1.55 146.60%
DPS 3.91 2.09 0.73 2.00 1.81 1.54 1.09 134.15%
NAPS 0.2716 0.2479 0.247 0.234 0.2394 0.2483 0.2429 7.72%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 0.835 5.29 3.26 5.00 4.32 2.22 1.26 -
P/RPS 0.27 3.51 1.08 0.48 0.54 0.40 0.40 -23.03%
P/EPS 12.61 187.92 36.88 47.56 33.39 17.91 14.69 -9.66%
EY 7.93 0.53 2.71 2.10 2.99 5.58 6.81 10.67%
DY 5.15 0.43 1.23 2.20 2.31 3.83 4.76 5.38%
P/NAPS 2.79 19.38 2.40 3.88 3.27 1.62 0.94 106.39%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 -
Price 0.845 0.925 4.03 3.49 5.72 4.42 1.88 -
P/RPS 0.27 0.61 1.33 0.33 0.72 0.79 0.60 -41.24%
P/EPS 12.76 32.86 45.59 33.20 44.21 35.66 21.93 -30.28%
EY 7.84 3.04 2.19 3.01 2.26 2.80 4.56 43.46%
DY 5.09 2.49 0.99 3.15 1.75 1.92 3.19 36.50%
P/NAPS 2.83 3.39 2.96 2.71 4.33 3.23 1.40 59.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment